CoChat

Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes

Open access
Wang, Hong, Diaz, Alexander K., Shaw, Timothy I., Li, Yuxin, Niu, Mingming, Cho, Ji-Hoon, Paugh, Barbara S., Zhang, Yang, Sifford, Jeffrey, Bai, Bing, Wu, Zhiping, Tan, Haiyan, Zhou, Suiping, Hover, Laura D., Tillman, Heather S., Shirinifard, Abbas, Thiagarajan, Suresh, Sablauer, Andras, Pagala, Vishwajeeth, High, Anthony A., Wang, Xusheng, Li, Chunliang, Baker, Suzanne J., Peng, Junmin · 2019 · Nature Communications
Cited by 67

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

High throughput omics approaches provide an unprecedented opportunity for dissecting molecular mechanisms in cancer biology. Here we present deep profiling of whole proteome, phosphoproteome and transcriptome in two high-grade glioma (HGG) mouse models driven by mutated RTK oncogenes, PDGFRA and NTRK1, analyzing 13,860 proteins and 30,431 phosphosites by mass spectrometry. Systems biology approaches identify numerous master regulators, including 41 kinases and 23 transcription factors. Pathway activity computation and mouse survival indicate the NTRK1 mutation induces a higher activation of AKT downstream targets including MYC and JUN, drives a positive feedback loop to up-regulate multiple other RTKs, and confers higher oncogenic potency than the PDGFRA mutation. A mini-gRNA library CRISPR-Cas9 validation screening shows 56% of tested master regulators are important for the viability of NTRK-driven HGG cells, including TFs (Myc and Jun) and metabolic kinases (AMPK a 1 and AMPK a 2), confirming the validity of the multiomics integrative approaches, and providing novel tumor vulnerabilities.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-11661-4

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 48

  1. Drake, J. M. et al. Phosphoproteome integration reveals patient-specific networks in prostate cancer. Cell 166, 1041–1054 (2016). · DOI · Paper page
  2. Cohen, P. The origins of protein phosphorylation. Nat. Cell Biol. 4, E127–E130 (2002). · DOI · Paper page
  3. Li, Y. et al. JUMPg: an integrative proteogenomics pipeline identifying unannotated proteins in human brain and cancer cells. J. Proteome Res. 15, 2309–2320 (2016). · DOI · Paper page
  4. Chang, T. C. et al. The neoepitope landscape in pediatric cancers. Genome Med. 9, 78 (2017). · DOI
  5. Cheng, Y. et al. Partial loss of psychiatric risk gene Mir137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a. Nat. Neurosci. 21, 1689–1703 (2018). · DOI · Paper page
  6. Jones, C. & Baker, S. J. Unique genetic and epigenetic mechanisms driving paediatric diffuse high-grade glioma. Nat. Rev. Cancer 14, 651–661 (2014). · DOI · Paper page
  7. TCGA. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061–1068 (2008). · DOI · Paper page
  8. Wu, G. et al. The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat. Genet. 46, 444–450 (2014). · DOI · Paper page
  9. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science (New York, NY) 321, 1807–1812 (2008). · DOI · Paper page
  10. Mackay, A. et al. Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32, 520–537.e525 (2017). · DOI · Paper page
  11. Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550–563 (2016). · DOI · Paper page
  12. Huang, P. H., Xu, A. M. & White, F. M. Oncogenic EGFR signaling networks in glioma. Sci. Signal. 2, re6 (2009).
  13. Johnson, H. & White, F. M. Quantitative analysis of signaling networks across differentially embedded tumors highlights interpatient heterogeneity in human glioblastoma. J. Proteome Res. 13, 4581–4593 (2014). · DOI
  14. Frattini, V. et al. The integrated landscape of driver genomic alterations in glioblastoma. Nat. Genet. 45, 1141–1149 (2013). · DOI · Paper page
  15. Ozawa, T. et al. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas. Genes Dev. 24, 2205–2218 (2010). · DOI · Paper page
  16. Tan, H. et al. Refined phosphopeptide enrichment by phosphate additive and the analysis of human brain phosphoproteome. Proteomics 15, 500–507 (2015). · DOI · Paper page
  17. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinforma. 9, 559 (2008). · DOI · Paper page
  18. Zhou, F. et al. Genome-scale proteome quantification by DEEP SEQ mass spectrometry. Nat. Commun. 4, 2171 (2013). · DOI · Paper page
  19. Muller, G., Wied, S. & Frick, W. Cross talk of pp125(FAK) and pp59(Lyn) non-receptor tyrosine kinases to insulin-mimetic signaling in adipocytes. Mol. Cell. Biol. 20, 4708–4723 (2000). · DOI · Paper page
  20. Kaur, H. et al. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma. Cancer Lett. 377, 55–64 (2016). · DOI
  21. Alinari, L. et al. Combination anti-CD74 (milatuzumab) and anti-CD20 (rituximab) monoclonal antibody therapy has in vitro and in vivo activity in mantle cell lymphoma. Blood 117, 4530–4541 (2011). · DOI
  22. Brembeck, F. H., Rosario, M. & Birchmeier, W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr. Opin. Genet. Dev. 16, 51–59 (2006). · DOI · Paper page
  23. do Carmo, A., Balca-Silva, J., Matias, D. & Lopes, M. C. PKC signaling in glioblastoma. Cancer Biol. Ther. 14, 287–294 (2013). · DOI
  24. Chalhoub, N. & Baker, S. J. PTEN and the PI3-kinase pathway in cancer. Annu. Rev. Pathol. 4, 127–150 (2009). · DOI · Paper page
  25. Lopez, M., Nogueiras, R., Tena-Sempere, M. & Dieguez, C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat. Rev. Endocrinol. 12, 421–432 (2016). · DOI · Paper page
  26. Radu, M., Semenova, G., Kosoff, R. & Chernoff, J. PAK signalling during the development and progression of cancer. Nat. Rev. Cancer 14, 13–25 (2014). · DOI · Paper page
  27. Liu, R. et al. Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion. Proc. Natl. Acad. Sci. USA 105, 7570–7575 (2008). · DOI
  28. Wee, S. et al. Selective calcium sensitivity in immature glioma cancer stem cells. PloS ONE 9, e115698 (2014). · DOI
  29. Xie, Q. et al. Mitochondrial control by DRP1 in brain tumor initiating cells. Nat. Neurosci. 18, 501–510 (2015). · DOI · Paper page
  30. Fleuren, E. D. G., Zhang, L., Wu, J. & Daly, R. J. The kinome ‘at large’ in cancer. Nat. Rev. Cancer 16, 83–98 (2016). · DOI · Paper page
  31. Roopra, A., Qazi, R., Schoenike, B., Daley, T. J. & Morrison, J. F. Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes. Mol. Cell 14, 727–738 (2004). · DOI · Paper page
  32. Silva, C. H., Silva, M., Iulek, J. & Thiemann, O. H. Structural complexes of human adenine phosphoribosyltransferase reveal novel features of the APRT catalytic mechanism. J. Biomol. Struct. Dyn. 25, 589–597 (2008). · doi:10.1080/07391102.2008.10507205
  33. Johnson, R. A. et al. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466, 632–636 (2010). · DOI · Paper page
  34. Lee, E., Chuang, H. Y., Kim, J. W., Ideker, T. & Lee, D. Inferring pathway activity toward precise disease classification. PLoS Comput. Biol. 4, e1000217 (2008). · DOI · Paper page
  35. Erard, N., Knott, S. R. V. & Hannon, G. J. A CRISPR resource for individual, combinatorial, or multiplexed gene knockout. Mol. Cell 67, 348–354.e344 (2017). · DOI · Paper page
  36. Rauniyar, N. & Yates, J. R. 3rd Isobaric labeling-based relative quantification in shotgun proteomics. J. Proteome Res. 13, 5293–5309 (2014). · DOI · Paper page
  37. Cocco, E., Scaltriti, M. & Drilon, A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat. Rev. Clin. Oncol. 15, 731–747 (2018). · DOI · Paper page
  38. Jones, D. T. et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat. Genet. 45, 927–932 (2013). · DOI · Paper page
  39. Zhang, J. et al. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat. Genet. 45, 602–612 (2013). · DOI · Paper page
  40. Chhipa, R. R. et al. AMP kinase promotes glioblastoma bioenergetics and tumour growth. Nat. Cell Biol. 20, 823–835 (2018). · DOI
  41. Wang, X., Xie, J. & Proud, C. G. Eukaryotic elongation factor 2 kinase (eEF2K) in cancer. Cancers 9, 162 (2017). · DOI
  42. Lahiri, V., Hawkins, W. D. & Klionsky, D. J. Watch what you (self-) eat: autophagic mechanisms that modulate metabolism. Cell Metab. 29, 803–826 (2019). · DOI · Paper page
  43. Shirinifard, A., Thiagarajan, S., Vogel, P. & Sablauer, A. Detection of phenotypic alterations using high-content analysis of whole-slide images. J. Histochem. Cytochem. 64, 301–310 (2016). · DOI
  44. Macek, B., Mann, M. & Olsen, J. V. Global and site-specific quantitative phosphoproteomics: principles and applications. Annu. Rev. Pharmacol. Toxicol. 49, 199–221 (2009). · DOI · Paper page
  45. Ishihama, Y. et al. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteom. 4, 1265–1272 (2005). · DOI · Paper page
  46. Storey, J. D. & Tibshirani, R. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100, 9440–9445 (2003). · DOI · Paper page
  47. The ENCODE Project Consortium An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). · DOI · Paper page
  48. Vo, B. T. et al. Inactivation of Ezh2 upregulates Gfi1 and drives aggressive Myc-driven group 3 medulloblastoma. Cell Rep. 18, 2907–2917 (2017). · DOI

Cited by

See all 67

Metadata

Authors
Wang, H., Diaz, A. K., Shaw, T. I., Li, Y., Niu, M., Cho, J.-H., Paugh, B. S., Zhang, Y., Sifford, J., Bai, B., Wu, Z., Tan, H., Zhou, S., Hover, L. D., Tillman, H. S., Shirinifard, A., Thiagarajan, S., Sablauer, A., Pagala, V., High, A. A., Wang, X., Li, C., Baker, S. J., & Peng, J.
Venue
Nature Communications
Published
2019-08-16
Volume
10
Issue
1
Pages
3718-3718
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2967976704
Cited by
67
References
22
FWCI
6.14
Type
journal article
Language
en
Open access
gold
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes. https://app.cochat.ai/papers/10.1038/s41467-019-11661-4
The paper
Wang, H., Diaz, A. K., Shaw, T. I., Li, Y., Niu, M., Cho, J.-H., Paugh, B. S., Zhang, Y., Sifford, J., Bai, B., Wu, Z., Tan, H., Zhou, S., Hover, L. D., Tillman, H. S., Shirinifard, A., Thiagarajan, S., Sablauer, A., Pagala, V., . . . Peng, J. (2019). Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes. Nature Communications. https://doi.org/10.1038/s41467-019-11661-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.